0000899243-21-025975.txt : 20210625 0000899243-21-025975.hdr.sgml : 20210625 20210625170032 ACCESSION NUMBER: 0000899243-21-025975 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210623 FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayweg Alexander CENTRAL INDEX KEY: 0001786260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40522 FILM NUMBER: 211048783 MAIL ADDRESS: STREET 1: C/O VERSANT VENTURES, AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc. CENTRAL INDEX KEY: 0001826457 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET STREET 2: SUITE 102 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-949-2643 MAIL ADDRESS: STREET 1: 645 SUMMER STREET STREET 2: SUITE 102 CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-23 0 0001826457 Monte Rosa Therapeutics, Inc. GLUE 0001786260 Mayweg Alexander MONTE ROSA THERAPEUTICS, INC. 645 SUMMER STREET, SUITE 102 BOSTON MA 02210 1 0 0 0 Stock Option (Right to Buy) 19.00 2021-06-23 4 A 0 47132 0.00 A 2031-06-22 Common Stock 47132 47132 D This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on June 28, 2021. /s/ Ajim Tamboli, Attorney-in-Fact 2021-06-25